| FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2 T Brevini, M Maes, GJ Webb, BV John, CD Fuchs, G Buescher, L Wang, ... Nature 615 (7950), 134-142, 2023 | 162 | 2023 |
| Migratory Metrics of Wound Healing: A Quantification Approach for in vitro Scratch Assays SS Varankar, SA Bapat Frontiers in Oncology 8, 633, 2018 | 27 | 2018 |
| Functional balance between Tcf21–Slug defines cellular plasticity and migratory modalities in high grade serous ovarian cancer cell lines SS Varankar, M More, A Abraham, K Pansare, B Kumar, NJ Narayanan, ... Carcinogenesis 41 (4), 515-526, 2020 | 16 | 2020 |
| Functional balance between TCF21-Slug defines phenotypic plasticity and sub-classes in high-grade serous ovarian cancer SS Varankar, SC Kamble, AM Mali, MM More, A Abraham, B Kumar, ... BioRxiv, 307934, 2018 | 12 | 2018 |
| FXR inhibition reduces ACE2 expression T Brevini, M MAES, GJ WEBB, WTH GELSON, S FORREST, ... SARS-CoV-2 infection and may improve COVID-19 outcome. bioRxiv 2006, 2021 | 5 | 2021 |
| Uncoupling Traditional Functionalities of Metastasis: The Parting of Ways with Real-Time Assays V Sagar S, B Sharmila A Journal of Clinical Medicine 8 (7), 2019 | 3 | 2019 |
| A monoclonal antibody against annexin A2 targets stem and progenitor cell fractions in tumors RS Kalra, GS Soman, PB Parab, AM Mali, SS Varankar, RR Naik, ... Translational Oncology 15 (1), 101257, 2022 | 2 | 2022 |
| Cell geometry distinguishes migration‐associated heterogeneity in two‐dimensional systems SS Varankar, K Hari, S Kartika, SA Bapat, MK Jolly Computational and Systems Oncology 2 (3), e1041, 2022 | 1 | 2022 |
| A Multistep Tumor Growth Model of High-Grade Serous Ovarian Carcinoma Identifies Hypoxia-Associated Signatures MH More, SS Varankar, RR Naik, RD Dhake, P Ray, RM Bankar, AM Mali, ... Cells Tissues Organs, 1-17, 2022 | 1 | 2022 |
| Ex situ-armus: experimental models for combating respiratory dysfunction SS Varankar, EC Cardoso, JH Lee Current Opinion in Genetics & Development 75, 101946, 2022 | 1 | 2022 |
| FXR INHIBITION AS A NEW STRATEGY AGAINST COVID19 T Brevini1, M Maes2, GJ Webb3, CD Fuchs4, G Buescher5 L Wang, C Griffiths, M Brown, WE Scott, P Pereyra Gerber, WT Gelson, ... United European Gastroenterology Journal, 210-211, 2022 | | 2022 |
| FXR inhibition reduces ACE2 expression, SARS-CoV-2 infection and may improve COVID-19 outcome (preprint) T Brevini, M Maes, GJ Webb, WTH Gelson, S Forrest, P Mlcochova, ... | | 2021 |
Mohit Kumar JollyAssociate Professor, Indian Institute of Science, BangaloreVerified email at iisc.ac.in
